COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 962: Articles 9611-9620  | Next

COVID-19 mortality in the United States: It's been two Americas from the start
Stoto, M., Schlageter, S., Kraemer, J. A.
10.1101/2022.02.23.22271411 — Posted: 2022-02-24
Genomic surveillance of SARS-CoV-2 reveals emergence of Omicron BA.2 in Islamabad, Pakistan
Umair, M., Ikram, A., Rehman, Z., Haider, S. A., Ammar, M., Badar, N., Ali, Q., Rana, M. S., Salman, M.
10.1101/2022.02.23.22271372 — Posted: 2022-02-24
Quantifying antibody dynamics of severe and non-severe patients with COVID-19
Ordonez-Jimenez, F., Blanco-Rodriguez, R., Almocera, A. E. S., Chinney-Herrera, G., Hernandez Vargas, E. A.
10.1101/2022.02.23.22271403 — Posted: 2022-02-24
Dynamics of the Delta and Omicron variants of SARS-CoV-2 in the United States: the battle of supremacy in the presence of vaccination, mask usage and antiviral treatment
Ngonghala, C. N., Taboe, H. B., Gumel, A. B.
10.1101/2022.02.23.22271394 — Posted: 2022-02-24
Fourth Wave of COVID-19 in India : Statistical Forecasting
Rajeshbhai, S. P., Dhar, S. S., Shalabh, S.
10.1101/2022.02.23.22271382 — Posted: 2022-02-24
Bounce backs amid continued losses: Life expectancy changes since COVID-19
Schoeley, J., Aburto, J. M., Kashnitsky, I., Kniffka, M. S., Zhang, L., Jaadla, H., Dowd, J. B., Kashyap, R.
10.1101/2022.02.23.22271380 — Posted: 2022-02-24
Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study
Ayoubkhani, D., Bosworth, M. L., King, S., Pouwels, K. B., Glickman, M., Nafilyan, V., Zaccardi, F., Khunti, K., Alwan, N. A., Walker, A. S.
10.1101/2022.02.23.22271388 — Posted: 2022-02-24 Discussion: Onsite
Increase in SARS-CoV-2 RBD-specific IgA and IgG Antibodies in Breast Milk from Lactating Women Following the COVID-19 Booster Vaccination
Henle, A. M.
10.1101/2022.02.23.22271414 — Posted: 2022-02-24
Third dose of COVID-19 vaccine, CVnCoV, increased neutralizing activity against SARS-CoV-2 wild-type and Delta variant
Wolz, O.-O., Kays, S.-K., Junker, H., Koch, S. D., Mann, P., Quintini, G., von Eisenhart-Rothe, P., Oostvogels, L.
10.1101/2022.02.22.22271051 — Posted: 2022-02-24
Bacterial metatranscriptomes in wastewater can differentiate virally infected human populations
Salido, R. A., Martino, C., Karthikeyan, S., Huang, S., Rahman, G., Gonzalez, A., Zaramela, L. S., Beck, K. L., Bhute, S., Cantrell, K., Carrieri, A. P., Farmer, S., Haiminen, N., Humphrey, G., Kim, H.-C., Parida, L., Richter, R. A., Vazquez-Baeza, Y., Zengler, K., Swafford, A., Bartko, A., Knight, R.
10.1101/2022.02.23.481658 — Posted: 2022-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).